Effects of long-term, continuous subcutaneous apomorphine infusions on motor complications in advanced Parkinson's disease.
Wenning
G K
GK
Department of Neurology, University Hospital, Innsbruck, Austria.
Bösch
S
S
Luginger
E
E
Wagner
M
M
Poewe
W
W
D000978:Antiparkinson Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D001058:Apomorphine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007279:Injections, Subcutaneous; D009069:Movement Disorders / Q000188:drug therapy* / Q000209:etiology*; D010300:Parkinson Disease / Q000150:complications* / Q000503:physiopathology; D013997:Time Factors
D000978:Antiparkinson Agents; D001058:Apomorphine